RESEARCH-USE BIOSIMILAR ANTIBODY
Naxitamab
Monoclonal antibody · IgG1
Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers.
TARGETGanglioside GD2
YMonoclonal antibody
CATALOGSC-BS-359
CATALOG NUMBERSC-BS-359
MOLECULAR WEIGHTApprox. 144.38 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers.
Naxitamab is a recombinant research-use antibody directed against Ganglioside GD2.